Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia

Search results

• The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and

  Douxfils, J., Mullier, F., Haguet, H. & RONVAUX, L.

  1/09/15 → …

  Project: Research

  • Protein Tyrosine Kinase Inhibitor 100%
  • Chronic Myeloid Leukemia 60%
  • Tyrosine-Kinase Inhibitor 50%
  • In Vitro 50%
  • Endothelial Cell 50%